Jakob Gäbel
Sahlgrenska University Hospital
11 Papers
5 Citations
Jakob Gäbel is an academic researcher from Sahlgrenska University Hospital. The author has contributed to research in topics: Medicine & Heart transplantation. The author has an hindex of 8, co-authored 11 publications. Previous affiliations of Jakob Gäbel include University of Gothenburg.
Chat about Author
Papers
A single-centre experience of over one thousand lead extractions.
TL;DR: Laser-assisted lead extraction proved to be a useful technique to extract leads that could not be removed by manual traction, indicating that the paradigm of abandoning redundant leads, instead of removing them, may have to be reconsidered.
218
Continuous improvement in outcome after heart transplantation - Long-term follow-up after three decades of experience.
Göran Dellgren,Göran Dellgren,Andreas Westerlind,Hans Liden,Jakob Gäbel,S. Bartfay,Entela Bollano,Erik Holmberg,Bert Andersson,Henrik Scherstén,Kristjan Karason +10 more
TL;DR: It is shown that continuous improvement in outcome after HTx still occurs, and direct transplantation from short-term MCS was abandoned, which may have inflicted outcome during the last time era.
21
Are biventricular assist devices underused as a bridge to heart transplantation in patients with a high risk of postimplant right ventricular failure
S. Bartfay,Göran Dellgren,Göran Dellgren,Hans Liden,Hans Liden,Mikael Holmberg,Mikael Holmberg,Jakob Gäbel,Jakob Gäbel,Bengt Redfors,Bengt Redfors,Odd Bech-Hanssen,Odd Bech-Hanssen,Kristjan Karason,Kristjan Karason +14 more
TL;DR: Planned in advance, the biventricular assist device seems to be a feasible option as bridge to heart transplantation for patients with a high risk of postimplant right ventricular failure.
20
The BiVAD experience at the university hospital, results from the years 2010 to 2012 and comparison with contemporary LVAD patients
S. Bartfay,Hans Liden,M. Holmberg,Kristjan Karason,Jakob Gäbel,Nedim Selimovic,Göran Dellgren +6 more
TL;DR: Biventricular assist device is a good treatment option in selected patients with advanced biventricul heart failure and the results in this very sick group of patients are much more encouraging than earlier described.